Oral Ciprofloxacin Dosing for eGFR 10 mL/min/1.73 m²
For an adult with eGFR 10 mL/min/1.73 m², reduce oral ciprofloxacin dose by 50% and extend the dosing interval to every 18-24 hours (e.g., 250-500 mg every 18-24 hours depending on infection severity).
Dosing Algorithm Based on Renal Function
The FDA-approved ciprofloxacin label provides explicit guidance for renal dose adjustment 1:
- eGFR >50 mL/min/1.73 m²: Standard dosing (no adjustment needed)
- eGFR 30-50 mL/min/1.73 m²: 250-500 mg every 12 hours
- eGFR 5-29 mL/min/1.73 m²: 250-500 mg every 18 hours
- Hemodialysis or peritoneal dialysis: 250-500 mg every 24 hours (after dialysis)
Your patient with eGFR 10 falls into the 5-29 mL/min/1.73 m² category, requiring dosing every 18 hours.
Rationale for Dose Reduction
Ciprofloxacin is eliminated primarily through renal excretion (40-50% unchanged in urine), with additional clearance through hepatic metabolism and biliary/intestinal pathways 1. The KDIGO guideline on antimicrobial dosing in CKD explicitly recommends reducing fluoroquinolone doses by 50% when eGFR <15 mL/min/1.73 m² 2.
Research demonstrates that in severe renal impairment (creatinine clearance <30 mL/min/1.73 m²):
- AUC doubles compared to normal renal function 3
- Renal clearance decreases to one-fourth of normal 3
- Elimination half-life increases by approximately 1.7-fold 3
- Total clearance reduces by 50% 4, 3
Infection Severity Considerations
For mild-to-moderate infections (uncomplicated UTI, mild skin infections):
- 250 mg every 18 hours
For severe/complicated infections (complicated UTI, pyelonephritis, severe pseudomonal infections):
- 500 mg every 18 hours
- The FDA label specifically notes: "In patients with severe infections and severe renal impairment, a unit dose of 750 mg may be administered at the intervals noted above. Patients should be carefully monitored" 1
Critical Caveats
Urine concentrations remain therapeutic: Even with dose reduction, urinary ciprofloxacin concentrations remain well above MIC for most uropathogens (>30 μg/mL at 8-12 hours post-dose), making it effective for UTIs despite severe renal impairment 3
Monitor for accumulation: The prolonged half-life (approximately 7-10 hours in severe renal impairment vs. 4 hours in normal function) increases risk of accumulation with standard dosing 4, 5
Hemodialysis removes minimal drug: Dialysis clearance is only 40 mL/min with 23% extraction ratio, so supplemental dosing post-dialysis is generally not required beyond the standard reduced dose 4
Alternative pathways partially compensate: Hepatic metabolism and biliary/intestinal elimination provide approximately 50% of total clearance in severe renal impairment, which is why dose reduction is 50% rather than more dramatic 1
Avoid concurrent nephrotoxins: NSAIDs should be avoided in patients with eGFR <30 mL/min/1.73 m² per KDIGO guidelines 2